Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice

Experimental Neurology

Volumn 179, Issue 2, 2003, Pages 188-199

  Christianson, Julie A ^a   Riekhof, John T ^a   Wright, Douglas E ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

GDNF; Hyperglycemia; Neuropathy; Neurturin; NGF; Peripheral afferent; Streptozotocin

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN; NEURTURIN; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; FOOT PAD; HINDLIMB; HYPERGLYCEMIA; INNERVATION; MALE; MOUSE; NERVE FIBER; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SKIN; TREATMENT OUTCOME;

EID: 0037332095     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(02)00017-1     Document Type: Article

References (47)

1. Airaksinen M.S., Titievsky A., Saarma M. GDNF family neurotrophic factor signaling four masters, one servant? Mol. Cell Neurosci. 13:1999;313-325.
2. Akkina S.K., Patterson C.L., Wright D.E. GDNF rescues nonpeptidergic unmyelinated primary afferents in streptozotocin-treated diabetic mice. Exp. Neurol. 167:2001;173-182.
3. Apfel S.C. Neurotrophic factors in peripheral neuropathies therapeutic implications . Brain Pathol. 9:1999;393-413.
4. Apfel S.C., Schwartz S., Adornato B.T., Freeman R., Biton V., Rendell M., Vinik A., Giuliani M., Stevens J.C., Barbano R., Dyck P.J. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy a randomized controlled trial. rhNGF Clinical Investigator Group . J. Am. Med. Assoc. 284:2000;2215-2221.
5. Averill S., McMahon S.B., Clary D.O., Reichardt L.F., Priestley J.V. Immunocytochemical localization of trkA receptors in chemically identified subgroups of adult rat sensory neurons. Eur. J. Neurosci. 7:1995;1484-1494.
6. Bennett D.L., Averill S., Clary D.O., Priestley J.V., McMahon S.B. Postnatal changes in the expression of the trkA high-affinity NGF receptor in primary sensory neurons. Eur. J. Neurosci. 8:1996;2204-2208.
7. Bennett D.L., Dmietrieva N., Priestley J.V., Clary D., McMahon S.B. trkA, CGRP and IB4 expression in retrogradely labelled cutaneous and visceral primary sensory neurones in the rat. Neurosci. Lett. 206:1996;33-36.
8. Bennett D.L., Michael G.J., Ramachandran N., Munson J.B., Averill S., Yan Q., McMahon S.B., Priestley J.V. A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J. Neurosci. 18:1998;3059-3072.
9. Bradbury E.J., Burnstock G., McMahon S.B. The expression of P2X3 purinoreceptors in sensory neurons effects of axotomy and glial-derived neurotrophic factor . Mol. Cell. Neurosci. 12:1998;256-268.
10. Brewster W.J., Diemel L.T., Leach R.M., Tomlinson D.R. Reduced sciatic nerve substance P and calcitonin gene-related peptide in rats with short-term diabetes or central hypoxaemia co-exist with normal messenger RNA levels in the lumbar dorsal root ganglia. Neuroscience. 58:1994;323-330.
11. Carlsten J.A., Kothary R., Wright D.E. Glial cell line-derived neurotrophic factor-responsive and neurotrophin-3-responsive neurons require the cytoskeletal linker protein dystonin for postnatal survival. J. Comp. Neurol. 432:2001;155-168.
12. Carr P.A., Yamamoto T., Nagy J.I. Calcitonin gene-related peptide in primary afferent neurons of rat co-existence with fluoride-resistant acid phosphatase and depletion by neonatal capsaicin . Neuroscience. 36:1990;751-760.
13. Cockayne D.A., Hamilton S.G., Zhu Q.M., Dunn P.M., Zhong Y., Novakovic S., Malmberg A.B., Cain G., Berson A., Kassotakis L., Hedley L., Lachnit W.G., Burnstock G., McMahon S.B., Ford A.P. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature. 407:2000;1011-1015.
14. Diamond J., Holmes M., Coughlin M. Endogenous NGF and nerve impulses regulate the collateral sprouting of sensory axons in the skin of the adult rat. J. Neurosci. 12:1992;1454-1466.
15. Diamond J., Coughlin M., MacIntyre L., Holmes M., Visheau B. Evidence that endogenous nerve growth factor is responsible for the collateral sprouting, but not regeneration of nociceptive axons in adult rats. Proc. Natl. Acad. Sci. USA. 84:1987;6596-6600.
16. Diamond J., Foerster A., Holmes M., Coughlin M. Sensory nerves in adult rats regenerate and restore sensory function to the skin independently of endogenous NGF. J. Neurosci. 12:1992;1467-1476.
17. Diemel L.T., Cai F., Anand P., Warner G., Kopleman P.G., Fernyhough P., Tomlinson D.R. Increased nerve growth factor mRNA in lateral calf skin biopsies from diabetic patients. Diabetes Med. 16:1999;113-118.
18. Faradji V., Sotelo J. Low serum levels of nerve growth factor in diabetic neuropathy. Acta Neurol. Scand. 81:1990;402-406.
19. Fernyhough P., Diemel L.T., Tomlinson D.R. Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Diabetologia. 41:1998;300-306.
20. Fox A., Eastwood C., Gentry C., Manning D., Urban L. Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain. 81:1999;307-316.
21. Hellweg R., Hartung H.D. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus a possible role for NGF in the pathogenesis of diabetic neuropathy . J. Neurosci. Res. 26:1990;258-267.
22. Herrmann D.N., Griffin J.W., Hauer P., Cornblath D.R., McArthur J.C. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology. 53:1999;1634-1640.
23. Hirai A., Yasuda H., Joko M., Maeda T., Kikkawa R. Evaluation of diabetic neuropathy through the quantitation of cutaneous nerves. J. Neurol. Sci. 172:2000;55-62.
24. Huang E.J., Reichardt L.F. Neurotrophins roles in neuronal development and function . Annu. Rev. Neurosci. 24:2001;677-736.
25. Hunt S.P., Rossi J. Peptide- and non-peptide-containing unmyelinated primary afferents the parallel processing of nociceptive information . Philos. Trans. R. Soc. London B Biol. Sci. 308:1985;283-289.
26. Hylden J.L., Wilcox G.L. Intrathecal morphine in mice a new technique . Eur. J. Pharmacol. 67:1980;313-316.
27. Karanth S.S., Springall D.R., Francavilla S., Mirrlees D.J., Polak J.M. Early increase in CGRP- and VIP-immunoreactive nerves in the skin of streptozotocin-induced diabetic rats. Histochemistry. 94:1990;659-666.
28. Kennedy W.R., Wendelschafer-Crabb G., Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology. 47:1996;1042-1048.
29. Kennedy A.J., Wellmer A., Facer P., Saldanha G., Kopelman P., Lindsay R.M., Anand P. Neurotrophin-3 is increased in skin in human diabetic neuropathy. J. Neurol. Neurosurg. Psychiatry. 65:1998;393-395.
30. Kitchener P.D., Wilson P., Snow P.J. Selective labelling of primary sensory afferent terminals in lamina II of the dorsal horn by injection of Bandeiraea simplicifolia isolectin B4 into peripheral nerves. Neuroscience. 54:1993;545-551.
31. Knyihar-Csillik E., Bezzegh A., Boti S., Csillik B. Thiamine monophosphatase agenuine marker for transganglionic regulation of primary sensory neurons . J. Histochem. Cytochem. 34:1986;363-371.
32. Lee P.G., Hohman T.C., Cai F., Regalia J., Helke C.J. Streptozotocin-induceddiabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve. Exp. Neurol. 170:2001;149-161.
33. Leitner M.L., Molliver D.C., Osborne P.A., Vejsada R., Golden J.P., Lampe P.A., Kato A.C., Milbrandt J., Johnson E.M. Jr. Analysis of the retrograde transport of glial cell line-derived neurotrophic factor (GDNF), neurturin, and persephin suggests that in vivo signaling for the GDNF family is GFRalpha coreceptor-specific. J. Neurosci. 19:1999;9322-9331.
34. Levy D.M., Karanth S.S., Springall D.R., Polak J.M. Depletion of cutaneous nerves and neuropeptides in diabetes mellitus an immunocytochemical study . Diabetologia. 32:1989;427-433.
35. Levy D.M., Terenghi G., Gu X.-H., Abraham R.R., Springall D.R., Polak J.M. Immunohistochemical measurements of nerves and neuropeptides in diabetic skin relationship to tests of neurological function . Diabetologia. 35:1992;889-897.
36. McCarthy B.G., Hsieh S.T., Stocks A., Hauer P., Macko C., Cornblath D.R., Griffin J.W., McArthur J.C. Cutaneous innervation in sensory neuropathies evaluation by skin biopsy . Neurology. 45:1995;1848-1855.
37. Molliver D.C., Radeke M.J., Feinstein S.C., Snider W.D. Presence or absence of TrkA protein distinguishes subsets of small sensory neurons with unique cytochemical characteristics and dorsal horn projections. J. Comp. Neurol. 361:1995;404-416.
38. Molliver D.C., Snider W.D. Nerve growth factor receptor TrkA is down-regulated during postnatal development by a subset of dorsal root ganglion neurons. J. Comp. Neurol. 381:1997;428-438.
39. Molliver D.C., Wright D.E., Leitner M.L., Parsadanian A.S., Doster K., Wen D., Yan Q., Snider W.D. IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life. Neuron. 19:1997;849-861.
40. Nolano M., Simone D.A., Wendelschafer-Crabb G., Johnson T., Hazen E., Kennedy W.R. Topical capsaicin in humans parallel loss of epidermal nerve fibers and pain sensation . Pain. 81:1999;135-145.
41. 4. Somat. Motil. Res. 14:1997;17-26.
42. Schmidt R.E., Dorsey D.A., Roth K.A., Parvin C.A., Hounsom L., Tomlinson D.R. Effect of streptozotocin-induced diabetes on NGF, P75(NTR) and TrkA content of prevertebral and paravertebral rat sympathetic ganglia. Brain Res. 867:2000;149-156.
43. Silverman J.D., Kruger L. Lectin and neuropeptide labeling of separate populations of dorsal root ganglion neurons and associated "nociceptor" thin axons in rat testis and cornea whole-mount preparations. Somatosens. Res. 5:1988;259-267.
44. Snider W.D., McMahon S.B. Tackling pain at the source new ideas about nociceptors . Neuron. 20:1998;629-632.
45. Underwood R.A., Gibran N.S., Muffley L.A., Usui M.L., Olerud J.E. Color subtractive-computer-assisted image analysis for quantification of cutaneous nerves in a diabetic mouse model. J. Histochem. Cytochem. 49:2001;1285-1291.
46. Vulchanova L., Riedl M.S., Shuster S.J., Stone L.S., Hargreaves K.M., Buell G., Surprenant A., North R.A., Elde R. P2X3 is expressed by DRG neurons that terminate in inner lamina II. Eur. J. Neurosci. 10:1998;3470-3478.
47. Wang Z., Dohle C., Friemann J., Green B.S., Gleichmann H. Prevention of high- and low-dose STZ-induced diabetes with D-glucose and 5-thio-D-glucose. Diabetes. 42:1993;420-428.